I hereby claim:
- I am martinchapman on github.
- I am martinchapman (https://keybase.io/martinchapman) on keybase.
- I have a public key ASDYk54bUmJiPg38ZFA8aBN6XTYUf12pn2tR5ln0Qvk6Cgo
To claim this, I am signing this object:
| services: | |
| mesa-local: | |
| image: ghcr.io/londonaicentre/mesa-deploy/mesa-local | |
| pull_policy: always | |
| environment: | |
| - MODEL_NAME=${MODEL_NAME:-oncoqwen_1_0_0} | |
| - WEIGHTS_ID=${WEIGHTS_ID} | |
| - WEIGHTS_KEY=${WEIGHTS_KEY} | |
| - MAX_MODEL_LEN=${MAX_MODEL_LEN:-39067} # adjust for gpu mem size | |
| volumes: |
| [ | |
| {"document_id": "5609cc8b-f83b-443c-9583-364c188b4dc8", "document_content": "Oncology MDT Letter – Outpatient Clinic Date: 14th March 2024 Dear Dr. Patel, Thank you for referring Mrs. Eleanor Hughes, a 58-year-old woman, regarding her known metastatic non-small cell lung carcinoma, initially diagnosed in September 2021. This represents a recurrence of her previously treated early-stage disease. Disease Status & Staging Eleanor's primary tumour is a right upper lobe lung adenocarcinoma, staged at T3N2M1c (Group Stage IVb) at the time of metastatic diagnosis. Molecular profiling revealed an EGFR exon 19 deletion (VAF 34.2%), with PD-L1 expression of 60% positive. KRAS was negative. MSI testing confirmed microsatellite stable (MSS) disease. TMB was 6.2 mutations/Mb (TMB-low). Known sites of spread include bilateral mediastinal lymph nodes, a solitary liver metastasis (segment VI), and leptomeningeal disease confirmed on MRI in January 2024. Scores Performance status is ECOG 1 (\"she remains independently act |
| # Visualise a latex document git history | |
| # loop through commits, create a PDF from your main file for each | |
| # translate the pages of that PDF to a single image | |
| # create GIF/mp4 from the folder of images created | |
| # run within your local repository | |
| # prerequisites: ImageMagick and FFmpeg | |
| # create output folder |
I hereby claim:
To claim this, I am signing this object: